Search
for
Sort by
Research 841–870 of 1000+
- Pubertal Acne
- Use of platelet rich plasma for skin rejuvenation
- Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
- Alopecia Areata: An Updated Review for 2023
- Targeted transgenic expression of the mutation causing Hutchinson-Gilford progeria syndrome leads to proliferative and degenerative epidermal disease
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- Hirsutism, Normal Androgens and Diagnosis of PCOS
- Identification of Novel Mutations in Basic Hair Keratins hHb1 and hHb6 in Monilethrix: Implications for Protein Structure and Clinical Phenotype
- Coronavirus Infection and Cholesterol Metabolism
- Treatment of pediatric alopecia areata: A systematic review
- Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90
- Mice Engrafted with Human Fetal Thymic Tissue and Hematopoietic Stem Cells Develop Pathology Resembling Chronic Graft-versus-Host Disease
- The Role of Exosomes Derived From Mesenchymal Stromal Cells in Dermatology
- Quality of life in children and adolescents with alopecia areata—A systematic review
- Skin inflammation activates intestinal stromal fibroblasts and promotes colitis
- Hair miR‐29a levels are decreased in patients with scleroderma
- Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- Colchicine in Managing Skin Conditions: A Systematic Review
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Lifestyle Factors Involved in the Pathogenesis of Alopecia Areata
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- Laser-Induced Koebner-Related Skin Reactions: A Clinical Overview
- Health Related Quality of Life of Rosacea Patients in China Assessed by Dermatology Life Quality Index and Willingness to Pay